Back to Search
Start Over
Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block.
- Source :
-
American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2017 Sep 01; Vol. 313 (3), pp. H631-H640. Date of Electronic Publication: 2017 Jun 16. - Publication Year :
- 2017
-
Abstract
- The signature lesion of SSA/Ro autoantibody-associated congenital heart block (CHB) is fibrosis and a macrophage infiltrate, supporting an experimental focus on cues influencing the fibroblast component. The transcriptomes of human fetal cardiac fibroblasts were analyzed using two complementary approaches. Cardiac injury conditions were simulated in vitro by incubating human fetal cardiac fibroblasts with supernatants from macrophages transfected with the SSA/Ro-associated noncoding Y ssRNA. The top 10 upregulated transcripts in the stimulated fibroblasts reflected a type I interferon (IFN) response [e.g., IFN-induced protein 44-like (IFI44L), of MX dynamin-like GTPase (MX)1, MX2, and radical S -adenosyl methionine domain containing 2 (Rsad2)]. Within the fibrotic pathway, transcript levels of endothelin-1 (EDN1), phosphodiesterase (PDE)4D, chemokine (C-X-C motif) ligand (CXCL)2, and CXCL3 were upregulated, while others, including adenomedullin, RAP guanine nucleotide exchange factor 3 (RAPGEF3), tissue inhibitor of metalloproteinase (TIMP)1, TIMP3, and dual specificity phosphatase 1, were downregulated. Agnostic Database for Annotation, Visualization and Integrated Discovery analysis revealed a significant increase in inflammatory genes, including complement C3A receptor 1 (C3AR1), F2R-like thrombin/trypsin receptor 3, and neutrophil cytosolic factor 2. In addition, stimulated fibroblasts expressed high levels of phospho-MADS box transcription enhancer factor 2 [a substrate of MAPK5 (ERK5)], which was inhibited by BIX-02189, a specific inhibitor of ERK5. Translation to human disease leveraged an unprecedented opportunity to interrogate the transcriptome of fibroblasts freshly isolated and cell sorted without stimulation from a fetal heart with CHB and a matched healthy heart. Consistent with the in vitro data, five IFN response genes were among the top 10 most highly expressed transcripts in CHB fibroblasts. In addition, the expression of matrix-related genes reflected fibrosis. These data support the novel finding that cardiac injury in CHB may occur secondary to abnormal remodeling due in part to upregulation of type 1 IFN response genes. NEW & NOTEWORTHY Congenital heart block is a rare disease of the fetal heart associated with maternal anti-Ro autoantibodies which can result in death and for survivors, lifelong pacing. This study provides in vivo and in vitro transcriptome-support that injury may be mediated by an effect of Type I Interferon on fetal fibroblasts.<br /> (Copyright © 2017 the American Physiological Society.)
- Subjects :
- Adult
Antibodies, Antinuclear genetics
Antibodies, Antinuclear immunology
Cells, Cultured
Culture Media, Conditioned metabolism
Female
Fetal Heart immunology
Fetal Heart pathology
Fibroblasts pathology
Fibrosis
Gene Expression Regulation
Heart Block genetics
Heart Block immunology
Heart Block metabolism
Heart Block pathology
Humans
Inflammation Mediators immunology
Interferon Regulatory Factors genetics
Interferon Regulatory Factors metabolism
Interferon Type I immunology
Macrophages immunology
Macrophages metabolism
Myocardium
Paracrine Communication
Pregnancy
Transfection
Antibodies, Antinuclear metabolism
Fetal Heart metabolism
Fibroblasts metabolism
Gene Expression Profiling methods
Heart Block congenital
Inflammation Mediators metabolism
Interferon Type I metabolism
Transcriptome
Subjects
Details
- Language :
- English
- ISSN :
- 1522-1539
- Volume :
- 313
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- American journal of physiology. Heart and circulatory physiology
- Publication Type :
- Academic Journal
- Accession number :
- 28626076
- Full Text :
- https://doi.org/10.1152/ajpheart.00256.2017